3.3(top 13%)
Impact Factor
3.7(top 13%)
extended IF
92(top 4%)
H-Index
3.8K
authors
5.6K
papers
86.5K
citations
5.4K
citing journals
45K
citing authors

Most Cited Articles of Digestive and Liver Disease

TitleYearCitations
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease2010493
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome2015430
The changing pattern of epidemiology in hepatocellular carcinoma2010409
From the metabolic syndrome to NAFLD or vice versa?2010341
European experts consensus statement on cystic tumours of the pancreas2013306
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study2001303
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)2008287
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups2015279
The bile acid TGR5 membrane receptor: from basic research to clinical application2014266
Liver fibrosis: from the bench to clinical targets2004249
Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases2002232
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis2006228
Herbal medicine in the treatment of liver diseases2007227
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation2009212
Role of faecal calprotectin as non-invasive marker of intestinal inflammation2003212
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease2008209
OLGA staging for gastritis: a tutorial2008200
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial2015198
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation2005194
Non-alcoholic fatty liver disease pathogenesis: the present and the future2009190
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation2005187
Extrahepatic manifestations of chronic hepatitis C virus infection2014186
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach2007183
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study2000183
Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment2014180